United Therapeutics

TYVASO

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / TYVASO – J7686

Manufacturer:

United Therapeutics

Name:

TYVASO

HCPCS Code Descriptor:

Treprostinil, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, 1.74 mg

Category:

J Code

HCPCS:

J7686

NDC(s):

66302-0206-03, 66302-0206-04, 66302-0206-02, 66302-0206-01

Primary Type:

Cardiology

Generic/Specialty Status:

Single-Source

Route of Administration:

Inhalation

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About:

TYVASO is a Cardiology drug manufactured by United Therapeutics and administered via the Inhalation route of administration. The J Code: J7686 is aligned to the drug TYVASO.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

1/1/11

HCPCS Effective Date:

1/1/11

HCPCS Short Description:

Treprostinil, non-comp unit

Billing and Coding Guide:

Not Found

Patient Assistance:

https://www.unither.com/patients.html

TYVASO - J7686